Rotavirus Vaccines in China-Reference-Cited by-同舟云学术

Rotavirus Vaccines in China

Published:2018-08-31 Issue:4 Volume:1 Page:e181579
ISSN:2574-3805
Container-title:JAMA Network Open
language:en
Short-container-title:JAMA Netw Open

Author:

Kirkwood Carl D.¹,Steele A. Duncan¹

Affiliation:

1. Enteric and Diarrheal Disease, Bill and Melinda Gates Foundation, Seattle, Washington

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

http:///jamanetworkopen/article-pdf/1/4/e181579/17306799/kirkwood_2018_ic_180041.pdf

Reference10 articles.

1. Effectiveness of rotavirus vaccination: a systematic review of the first decade of global postlicensure data, 2006-2016.;Jonesteller;Clin Infect Dis,2017

2. A dose-escalation safety and immunogenicity study of a new live attenuated human rotavirus vaccine (Rotavin-M1) in Vietnamese children.;Dang;Vaccine,2012

3. Efficacy of a low-cost, heat-stable oral rotavirus vaccine in Niger.;Isanaka;N Engl J Med,2017

4. A randomized phase III clinical trial to assess the efficacy of a bovine-human reassortant pentavalent rotavirus vaccine in Indian infants.;Kulkarni;Vaccine,2017

5. Effectiveness of the live attenuated rotavirus vaccine produced by a domestic manufacturer in China studied using a population-based case-control design.;Zhen;Emerg Microbes Infect,2015

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rotavirus trends and distribution of genotypes before and during COVID‐19 pandemic era: Bangladesh, 2017–2021;Journal of Medical Virology;2024-05

2. Estimating the global impact of rotavirus vaccines on child mortality;International Journal of Infectious Diseases;2023-12

3. Genomic Analysis of Rwandan G9P[8] Rotavirus Strains Pre- and Post-RotaTeq® Vaccine Reveals Significant Distinct Sub-Clustering in a Post-Vaccination Cohort;Viruses;2023-11-25

4. Reassortment and genomic analysis of a G9P[8]-E2 rotavirus isolated in China;Virology Journal;2023-06-22

5. Anti-rotavirus antibody measurement in a rotavirus vaccine trial: Choice of vaccine antigen in immunoassays does matter;Human Vaccines & Immunotherapeutics;2023-01-02